Publication List 2022

1984-94, 1995, 1996, 1997, 1998, 1999, 2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022

8 （490）	Ehata S, Miyazono K. Bone Morphogenetic Protein Signaling in Cancer; Some Topics in the Recent 10 Years. Front Cell Dev Biol. 2022 May 25;10:883523. doi: 10.3389/fcell.2022.883523. eCollection 2022.
7 （489）	Nishida J, Miyakuni K, Miyazono K, Ehata S. *An in vivo* orthotopic serial passaging model for a metastatic renal cancer study.** STAR Protoc. 2022 Apr 18;3(2):101306. doi: 10.1016/j.xpro.2022.101306. eCollection 2022 Jun 17.
6 （488）	Tsubakihara Y, Ohata Y, Okita Y, Younis S, Eriksson J, Sellin ME, Ren J, Ten Dijke P, Miyazono K, Hikita A, Imamura T, Kato M, Heldin CH, Moustakas A. TGFβ selects for pro-stemness over pro-invasive phenotypes during cancer cell epithelial-mesenchymal transition. Mol Oncol. 2022 doi: 10.1002/1878-0261.13215. in press.
5 （487）	Miyazono K. Cherish JB, a unique journal that originated from Japan. J Biochem. 2022 in press.
4 （486）	Ogami T, Tamura Y, Toss K, Yuki K, Morikawa M, Tsutsumi S, Aburatani H, Miyazawa K, Miyazono K, Koinuma D. MAB21L4 regulates the TGF-β-induced expression of target genes in epidermal keratinocytes. J Biochem. 2022 in press.
3 （485）	Tamura Y, Tsutsumi S, Miyazono K, Koinuma D. PolyI:C attenuates TGF-β signaling to induce cytostasis of surrounding cells by secreted factors in triple-negative breast cancer. Cancer Sci. 2022 Mar;113(3):940-949.
2 （484）	Miyakuni K, Nishida J, Koinuma D, Nagae G, Aburatani H, Miyazono K, Ehata S. Genome-wide analysis of DNA methylation identifies the apoptosis-related gene UQCRH as a tumor suppressor in renal cancer. Mol Oncol. 2022 Feb;16(3):732-749.
1 （483）	Tanabe R, Miyazono K, Todo T, Saito N, Iwata C, Komuro A, Sakai S, Raja E, Koinuma D, Morikawa M, Westermark B, Heldin CH. PRRX1 induced by BMP signaling decreases tumorigenesis by epigenetically regulating glioma-initiating cell properties via DNA methyltransferase 3A. Mol Oncol. 2022 Jan;16(1):269-288.